Keywords: gsk, submits, final, data, fda, cervarix, bla

GSK submits final data to FDA from Cervarix BLA

Article | 02 April 2009

Print This

UK drug major GlaxoSmithKline has submitted final data from a Phase III pivotal study of cervical cancer vaccine Cervarix to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in